Commodore Capital LP Q3 2022 Filing
Filed November 14, 2022
Portfolio Value
$621.9B
Holdings
30
Report Date
Q3 2022
Filing Type
13F-HR
All Holdings (30 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | COGTCOGENT BIOSCIENCES INC | 4,319,940 | $64.5B | 10.36% | |
| 2 | XENEXENON PHARMACEUTICALS INC | 1,594,932 | $57.6B | 9.26% | |
| 3 | VRDNVIRIDIAN THERAPEUTICS INC | 2,696,340 | $55.3B | 8.89% | |
| 4 | BLUBELLUS HEALTH INC NEW | 5,128,557 | $54.2B | 8.71% | |
| 5 | MRUSMERUS N V | 2,615,762 | $52.4B | 8.43% | |
| 6 | CYTKCYTOKINETICS INC | 893,646 | $43.3B | 6.96% | |
| 7 | ACRSACLARIS THERAPEUTICS INC | 2,410,622 | $37.9B | 6.10% | |
| 8 | AKROAKERO THERAPEUTICS INC | 743,472 | $25.3B | 4.07% | |
| 9 | —SATSUMA PHARMACEUTICALS INC | 3,711,286 | $22.3B | 3.58% | |
| 10 | 1T7TRICIDA INC | 1,975,403 | $20.7B | 3.33% | |
| 11 | CBAYUSDCYMABAY THERAPEUTICS INC | 5,738,500 | $20.1B | 3.23% | |
| 12 | THRDTHIRD HARMONIC BIO INC | 1,018,569 | $19.3B | 3.11% | |
| 13 | SNDXSYNDAX PHARMACEUTICALS INC | 738,110 | $17.7B | 2.85% | |
| 14 | TCE2CELLDEX THERAPEUTICS INC NEW | 538,812 | $15.1B | 2.44% | |
| 15 | DAWNDAY ONE BIOPHARMACEUTICALS I | 739,661 | $14.8B | 2.38% | |
| 16 | ARWRARROWHEAD PHARMACEUTICALS IN | 404,078 | $13.4B | 2.15% | |
| 17 | KURAKURA ONCOLOGY INC | 899,407 | $12.3B | 1.98% | |
| 18 | ABOSACUMEN PHARMACEUTICALS INC | 1,100,000 | $11.0B | 1.77% | |
| 19 | KPTIEURKARYOPHARM THERAPEUTICS INC | 1,935,609 | $10.6B | 1.70% | |
| 20 | ALLKGUSDALLAKOS INC | 1,643,500 | $10.1B | 1.62% | |
| 21 | NVLSEURALPINE IMMUNE SCIENCES INC | 1,325,000 | $9.5B | 1.53% | |
| 22 | CELCCELCUITY INC | 920,464 | $9.2B | 1.49% | |
| 23 | ENTAENANTA PHARMACEUTICALS INC | 103,494 | $5.4B | 0.86% | |
| 24 | KALVKALVISTA PHARMACEUTICALS INC | 312,553 | $4.5B | 0.73% | |
| 25 | RZLTREZOLUTE INC | 1,210,000 | $3.3B | 0.53% | |
| 26 | ESPRESPERION THERAPEUTICS INC NE | 467,468 | $3.1B | 0.50% | |
| 27 | IMUXIMMUNIC INC | 893,013 | $2.8B | 0.45% | |
| 28 | —BCLS ACQUISITION CORP | 250,000 | $2.5B | 0.40% | |
| 29 | LRMRLARIMAR THERAPEUTICS INC | 750,000 | $2.4B | 0.39% | |
| 30 | TERNTERNS PHARMACEUTICALS INC | 205,870 | $1.2B | 0.20% |